Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Intravenous Ketamine in Treatment-Resistant Bipolar Depression

To see complete record on, please visit this link

Id: NCT00947791

Organisation Name: Icahn School of Medicine at Mount Sinai

Overal Status: Terminated

Start Date: July 2009

Last Update: May 17, 2017

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Brief Summary: The purpose of this study is to determine whether a single intravenous administration of an N-methyl-D-aspartate antagonist is safe and effective for the acute treatment of bipolar depression.

  • Bipolar Disorder

Total execution time in seconds: 0.22374296188354